ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L

Ronghao Wang, Wanying Lin, Chang-Yi Lin, Lei Li, Yin Sun, Chawnshang Chang

Cancer Letters · 2016 · 60 citations · 27 references

Concepts

References

27